708-1178

withdrawn

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
708 (USA) · Dr. Kim
consented 2013-12-29

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild ALCOHOL USE — outcome: RECOVERED/RESOLVED; onset 2014-03-24 (study day 86.0); relationship: NONE

mild assessed

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-09 (study day 71.0); relationship: PROBABLE

mild assessed

Mild APPLICATION SITE PRURITUS — outcome: RECOVERED/RESOLVED; onset 2014-03-09 (study day 71.0); relationship: PROBABLE

severe assessed

Severe ATRIAL FIBRILLATION — outcome: RECOVERED/RESOLVED; onset 2014-03-24 (study day 86.0); relationship: POSSIBLE; serious criteria: hospitalization

mild assessed

Mild CYSTITIS — outcome: RECOVERED/RESOLVED; onset 2014-03-24 (study day 86.0); relationship: REMOTE

severe assessed

Severe DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2014-03-24 (study day 86.0); relationship: POSSIBLE; serious criteria: hospitalization

mild assessed

Mild FLANK PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-19 (study day -10.0); relationship: NONE

mild assessed

Mild NASOPHARYNGITIS — outcome: RECOVERED/RESOLVED; onset 2014-03-01 (study day 63.0); relationship: NONE

mild assessed

Mild VENTRICULAR SEPTAL DEFECT — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-09 (study day 71.0); relationship: NONE

Data queries

No data queries.